Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samer Al Hadidi

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Clinical Hematology International|December 31, 2022
Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic ReviewAndrea Anampa-Guzmán, Sara Taveras Alam, Inas Abuali, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2024
Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignanciesSamer Al Hadidi, Helen E Heslop, Malcolm K Brenner, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2020
Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple MyelomaSamer Al Hadidi, Courtney Nicole Miller-Chism, Rammurti Kamble, et al.
BMJ Case Reports|July 9, 2017
A rare case of Epstein-Barr virus mucocutaneous ulcer of the colonMohammed Osman, Mohammed Al Salihi, Emad Abu Sitta, et al.
Clinical Hematology International|August 11, 2022
The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's MacroglobulinemiaObada Ababneh, Hassan Abushukair, Aref Qarqash, et al.
Oxford Medical Case Reports|March 30, 2018
Methicillin-resistant <i>Staphylococcus aureus</i> prostatic abscess after traumatic rectal injuryJoud Jarrah, Varun Samji, Meron Meshesha, et al.
Case Reports in Cardiology|August 17, 2017
Seizure Associated Takotsubo Syndrome: A Rare CombinationHtay Htay Kyi, Nour Aljariri Alhesan, Sunil Upadhaya, et al.
JAMA Network Open|April 20, 2022
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant NeoplasmsSamer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
Ejhaem|August 21, 2023
Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic reviewMohammad O Ali, Hafez M Abdullah, Khaldun Obeidat, et al.
Ejhaem|September 2, 2022
Gender disparities in multiple myeloma publicationsAala Dweik, Hadeel Dweik, Hira Mian, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Clinical Hematology International|December 31, 2022
Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic ReviewAndrea Anampa-Guzmán, Sara Taveras Alam, Inas Abuali, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2024
Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignanciesSamer Al Hadidi, Helen E Heslop, Malcolm K Brenner, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2020
Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple MyelomaSamer Al Hadidi, Courtney Nicole Miller-Chism, Rammurti Kamble, et al.
BMJ Case Reports|July 9, 2017
A rare case of Epstein-Barr virus mucocutaneous ulcer of the colonMohammed Osman, Mohammed Al Salihi, Emad Abu Sitta, et al.
Clinical Hematology International|August 11, 2022
The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's MacroglobulinemiaObada Ababneh, Hassan Abushukair, Aref Qarqash, et al.
Oxford Medical Case Reports|March 30, 2018
Methicillin-resistant <i>Staphylococcus aureus</i> prostatic abscess after traumatic rectal injuryJoud Jarrah, Varun Samji, Meron Meshesha, et al.
Case Reports in Cardiology|August 17, 2017
Seizure Associated Takotsubo Syndrome: A Rare CombinationHtay Htay Kyi, Nour Aljariri Alhesan, Sunil Upadhaya, et al.
JAMA Network Open|April 20, 2022
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant NeoplasmsSamer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
Ejhaem|August 21, 2023
Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic reviewMohammad O Ali, Hafez M Abdullah, Khaldun Obeidat, et al.
Ejhaem|September 2, 2022
Gender disparities in multiple myeloma publicationsAala Dweik, Hadeel Dweik, Hira Mian, et al.
Pageof 10